CARB-X
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global nonprofit partnership focused on supporting the development of new antibacterial products, [1] financed by the super-spooky BARDA and the Gates Foundation.
History
CARB-X launched July 28, 2016 as one of the world's largest public-private partnerships to accelerate global antibacterial innovation, including drugs, vaccines, rapid diagnostics and devices. CARB-X aims to invest up to $450 million over five years with the goal of accelerating the preclinical discovery and development of at least 20 new antibacterial products.[2]
Activities
"The CARB-X initiative plays an important role in BARDA's goal to catalyze the early stage development pipeline and enhance our national health security preparedness. CARB-X allows BARDA to tap into a partnership of co-funders, accelerators, and innovators who are pushing critical novel antimicrobials from discovery to the market to address the public health and national security concerns of antibiotic resistant bacteria."[3]
In May 2021, it funded SNIPR BIOME, "a leading CRISPR and microbiome biotech company" incorporated in Copenhagen, Denmark, with US $3.9 million. The company applies its CRISPR technologies to selectively target microbial pathogens and remodelling the microbiome.[4]
Board members
The Joint Oversight Board and Advisory Board members are not discloses.[5] The members are "a snapshot of their subject matter experts" as of November 2024.[6] Kevin Outterson, Executive Director of CARB-X in 2016, is a Professor of Law at Boston University.[2][7]
Finances
Many of the usual suspects, including the spooky BARDA, the Gates Foundation, and Wellcome Trust. Other funders include Germany's Federal Ministry of Education and Research (BMBF); the United Kingdom's Department of Health and Social Care(DHSC), through its Global Antimicrobial Resistance Innovation Fund (GAMRIF), the Public Health Agency of Canada (PHAC), the Novo Nordisk Foundation; and the Unites States' National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).[8]
Known member
1 of the 74 of the members already have pages here:
| Member | Description |
|---|---|
| Debra Goff | US doctor |
Sponsors
| Event | Description |
|---|---|
| BARDA | Responsible for bioterrorism "medical countermeasures" (i.e. the actual biological weapons, like "vaccines") |
| Bill & Melinda Gates Foundation | Very influential and rich foundation established to take leadership of global health. |
| National Institute of Allergy and Infectious Diseases | |
| Wellcome Trust | 4th wealthiest charitable foundation in the world |
References
- ↑ https://web.archive.org/web/20160802054526/http://www.bu.edu:80/law/faculty-scholarship/carb-x/
- ↑ a b https://carb-x.org/carb-x-news/carb-x-injects-up-to-48-million-to-accelerate-first-powered-by-carb-x-portfolio-of-drug-development-projects-to-tackle-antibiotic-resistance/
- ↑ https://carb-x.org/partners/funding-partners/
- ↑ https://carb-x.org/carb-x-news/carb-x-is-funding-snipr-biome-to-develop-a-crispr-engineered-drug-to-eradicate-escherichia-coli-e-coli-bacteria-in-cancer-patients-to-prevent-deadly-infections/
- ↑ https://carb-x.org/about/advisory-board
- ↑ https://carb-x.org/about/advisory-board/
- ↑ https://archive.is/9o8Zp
- ↑ https://carb-x.org/partners/funding-partners/
